←Back to Expert Scholars
Translational Medicine / 转化医学Squamous NSCLC Advances
Tony Mok
MD
🏢The Chinese University of Hong Kong🌐Hong Kong
Chairman, Department of Clinical Oncology
110
h-index
0
Key Papers
0
Key Contributions
👥Biography 个人简介
Tony Mok led IPASS establishing EGFR-directed therapy and has contributed to squamous NSCLC immunotherapy trials. His work spans Asian cooperative group studies across histologies. He is a globally recognized leader in thoracic oncology research.
Share:
🧪Research Fields 研究领域
IPASS trial
EGFR NSCLC
Squamous NSCLC
Asian trials
Immunotherapy
🎓Key Contributions 主要贡献
Representative Works 代表性著作
📄Data Sources 数据来源
Last updated: 2026-04-01 | All information from publicly available academic sources
Related Experts 相关专家
Antoni Ribas
UCLA Jonsson Comprehensive Cancer Center
Melanoma ImmunotherapyCheckpoint Inhibitors
Drew M. Pardoll
Johns Hopkins University
Cancer ImmunologyPD-1/PD-L1 Pathway
Padmanee Sharma
MD Anderson Cancer Center
Bladder Cancer ImmunotherapyImmune Profiling
Naiyer A. Rizvi
Columbia University Irving Medical Center
Lung Cancer ImmunotherapyTumor Mutational Burden
关注 Tony Mok 的研究动态
Follow Tony Mok's research updates
留下邮箱，当我们发布与 Tony Mok（The Chinese University of Hong Kong）相关的新研究或访谈时，我们会通知你。
Explore More Experts
Discover the researchers shaping the future of cancer treatment